Read + Share
Song C, Kendi AT, Shim JY, Jung D, et al. ER-/PR+ breast cancer is controlled more effectively with an inflammatory
inhibitor than hormonal inhibitor. Breast Cancer 2023 Mar 1. doi: 10.1007/s12282-023-01437.
PMID: 36859733
|
 |
|
Song C, Kendi AT, Shim JY, Jung D, et al. ER-/PR+ breast cancer is controlled more effectively with an inflammatory
inhibitor than hormonal inhibitor. Breast Cancer 2023 Mar 1. doi: 10.1007/s12282-023-01437.
PMID: 36859733
|
|
|
|